The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy
Alessandro Orsini(University of Pisa), Pasquale Striano(Great Ormond Street Hospital), Roberto Michelucci(Istituto delle Scienze Neurologiche di Bologna), Mariagrazia Esposito(University of Pisa), Angelo Valetto(University of Pisa), Niccolò Carli(University of Pisa), Diego Peroni, Veronica Bertini(University of Pisa), Berge A. Minassian(Southwestern Medical Center), Alice Bonuccelli(University of Pisa)
Cited by 87
Related Papers
Mapping the human genetic architecture of COVID-19
|Nature|2021|1.1k
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Mutations in NHLRC1 cause progressive myoclonus epilepsy
|Nature Genetics|2003|330
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
|The American Journal of Human Genetics|2019|310
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260